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DISCUSSION
Dr Eugene M. Langan III, MD (Greenville, SC). The group
from the University of Tennessee–Knoxville, now in concert with
the Montefiore group again, present their data on iliac artery
angioplasty and/or stenting. As this is the third consecutive year a
variant of this data is presented at this meeting, they have won a
virtual trifecta on iliac artery stenting.
This year they added to last year’s report and become
more specific to assess the effects of concomitant infrainguinal
reconstruction on iliac stent patency. Of the 394 iliac artery
stent procedures performed over a 52-year experience, 68, or
17%, in 62 patients were associated with poor distal runoff.
Distal revascularization was done in 31 patients, 25 or 81%, at
the same operative setting. Concerning to me is that 12 pa-
tients, or 44% of the combined group, underwent concomitant
lower extremity vascularization and iliac stenting for claudi-
cation. I would suggest that this is possibly overaggressive
therapy and that these patients may have significant im-
provement in ambulatory status without the added, more inva-
sive therapy. This also could be part of the reason that Dr
Timaran and his colleagues have found that distal revasculari-
zation at the same setting as iliac artery stenting may not always
be justified.
This paper also brings out a trend that is not highlighted
but is extremely important. There was a trend for improved limb
salvage with the combined procedures. This makes intuitive
sense. In our program, lower extremity revascularization is not
performed to assist in iliac artery endovascular intervention, but
to improve distal lower extremity perfusion. This seems to fit the
authors’ conclusion.
A point of interest and evolution in this group’s work is that
in this study all procedures were performed by vascular sur-
geons. In the original paper only 2 years ago, interventional
radiologists did the majority of the iliac interventions. This is a
change I applaud.
I have a few questions for Dr Timaran. Carlos, you state in
the manuscript that all revisions or occlusions were considered
a stent failure. I am unclear if this is a bypass graft revision
or a more proximal stent revision. If it is the bypass graft,
should this affect stent patency? Could you please comment on
this?
Next, in your previous studies renal failure was a marker for
iliac stenting failure. It makes sense that this would hold true for
patients requiring distal bypass. What is your opinion on the
change?
Last, we feel that there is great value to the profunda
femoral runoff, and at times will add profundaplasty to assist our
distal perfusion. Did your study point to any value of profunda-
plasty?
Dr Carlos H. Timaran. Regarding your first question, we
did try to separate primary iliac stent patency from the graft
patency of the infrainguinal arterial reconstructions. In most
cases, this was possible. We also used an extended
Cox regression model that allowed us to include time-depen-
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dent covariates such as the bypass graft patency, thus correlating
the patency of the two reconstructions.
The small number of patients did not allow us to evaluate all
risk factors. In a previous study, we found that renal insuffi-
ciency is an important risk factor in patients undergoing iliac
angioplasty and stenting, especially for those with critical isch-
emia. Because most patients in the present study had disabling
claudication, renal insufficiency was not a predictor of adverse
outcome in this series.
We identified only three patients with significant occlusive
disease of the profunda femoris artery who underwent a concom-
itant profundaplasty. Thus most patients in this study had a poor
runoff secondary to severe atherosclerotic occlusive disease involv-
ing the common femoral and/or the superficial femoral arteries.
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